Study design

prospective collection and retrospective alysis

Study time

2013.9-2019.9

Country

India

Object

patients who underwent RARP by a single surgical team. They enlisted men fulfilling the criteria of low-risk Pca which included prostate-specific antigen (PSA) level at diagnosis <10 ng/mL, clinical T stage of T1 or T2a and Gleason grade Group 1, as per tiol Comprehensive Cancer Network 2019. They included low-risk patients, who though eligible for AS, underwent RP within 3 months of diagnosis.

Inclusion criteria

Exclusion criteria included ongoing neoadjuvant androgen deprivation therapy.

Sample size

46

Topic classification

Other treatments，Local Experience

Keypoint

There is a 50% likelihood of upstaging or upgrading in Indian males with low-risk PCa eligible for AS.

Year